Ultradeep sequencing in the therapeutic management of HIV-1 infection at treatment initiation

被引:0
|
作者
Todesco, Eve [1 ,2 ,3 ,4 ]
Mercier-Darty, Melanie [5 ]
Jung, Matthieu [6 ]
Bottero, Julie [7 ]
Boyd, Anders [2 ]
Marcelin, Anne-Genevieve [1 ,2 ,3 ]
Calvez, Vincent [1 ,2 ,3 ]
Morand-Joubert, Laurence [1 ,2 ,4 ]
机构
[1] Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, F-75013 Paris, France
[2] Univ Paris 06, INSERM, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, F-75013 Paris, France
[3] Hop La Pitie Salpetriere, AP HP, Dept Virol, F-75013 Paris, France
[4] Hop St Antoine, AP HP, Dept Virol, F-75571 Paris, France
[5] Univ Paris Est, Hop Henri Mondor, AP HP, Dept Virol, Creteil, France
[6] Univ Montpellier 2, CNRS, Inst Biol Computat, LIRMM,UMR 5506, Montpellier, France
[7] Hop St Antoine, AP HP, Dept Infect Dis, F-75571 Paris, France
关键词
HIV-1 drug resistance; minority variants; virological failure; resistance genotyping; TRANSMITTED DRUG-RESISTANCE; PERSISTENCE; MUTATIONS; FAILURE; RISK;
D O I
10.1093/jac/dkv013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:1919 / 1920
页数:2
相关论文
共 50 条
  • [1] Characterization of HIV-1 diversity in various compartments at the time of primary infection by ultradeep sequencing
    Géraldine Gaube
    Alix Armero
    Maud Salmona
    Marie-Laure Néré
    Nadia Mahjoub
    Caroline Lascoux-Combe
    Audrey Gabassi
    Sébastien Gallien
    Ali Amara
    Jean Michel Molina
    Constance Delaugerre
    Marie-Laure Chaix
    Scientific Reports, 10
  • [2] Characterization of HIV-1 diversity in various compartments at the time of primary infection by ultradeep sequencing
    Gaube, Geraldine
    Armero, Alix
    Salmona, Maud
    Nere, Marie-Laure
    Mahjoub, Nadia
    Lascoux-Combe, Caroline
    Gabassi, Audrey
    Gallien, Sebastien
    Amara, Ali
    Molina, Jean Michel
    Delaugerre, Constance
    Chaix, Marie-Laure
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [3] THERAPEUTIC APPROACHES FOR THE TREATMENT OF HIV-1 INFECTION
    ADAMS, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 369 - ORGN
  • [4] Ultradeep sequencing reveals HIV-1 diversity and resistance compartmentalization during HIV-encephalopathy
    Giatsou, Eleni
    Abdi, Basma
    Plu, Isabelle
    Desire, Nathalie
    Palich, Romain
    Calvez, Vincent
    Seilhean, Danielle
    Marcelin, Anne-Genevieve
    Jary, Aude
    AIDS, 2020, 34 (11) : 1609 - 1614
  • [5] Therapeutic advances: protease inhibitors for the treatment of HIV-1 infection
    Misson, J
    Clark, W
    Kendall, MJ
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1997, 22 (02) : 109 - 117
  • [6] Therapeutic potential of neutralizing antibodies in the treatment of HIV-1 infection
    Stiegler, G
    Katinger, H
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (04) : 757 - 759
  • [7] The relevance of ultradeep sequencing for low HIV-1 viral loads and proviruses in the clinical setting
    Foury, Alizee
    Saunier, Aline
    Taverniers, Audrey
    Pinet, Nathalie
    Josse, Thomas
    Jeanmaire, Eliette
    Emilie, Caroline
    Schvoerer, Evelyne
    Hartard, Cedric
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (08)
  • [8] A Genotypic Test for HIV-1 Tropism Combining Sanger Sequencing with Ultradeep Sequencing Predicts Virologic Response in Treatment-Experienced Patients
    Kagan, Ron M.
    Johnson, Erik P.
    Siaw, Martin
    Biswas, Pinaki
    Chapman, Douglass S.
    Su, Zhaohui
    Platt, Jamie L.
    Pesano, Rick L.
    PLOS ONE, 2012, 7 (09):
  • [9] Deep sequencing for HIV-1 clinical management
    Casadella, Maria
    Paredes, Roger
    VIRUS RESEARCH, 2017, 239 : 69 - 81
  • [10] The trinity of the cortical actin in the initiation of HIV-1 infection
    Mark Spear
    Jia Guo
    Yuntao Wu
    Retrovirology, 9